APLM
Price
$6.51
Change
+$0.10 (+1.56%)
Updated
Jun 27 closing price
Capitalization
7.18M
BIXT
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
9.39M
Interact to see
Advertisement

APLM vs BIXT

Header iconAPLM vs BIXT Comparison
Open Charts APLM vs BIXTBanner chart's image
Apollomics
Price$6.51
Change+$0.10 (+1.56%)
Volume$8.49K
Capitalization7.18M
Bioxytran
Price$0.11
Change-$0.00 (-0.00%)
Volume$38.01K
Capitalization9.39M
APLM vs BIXT Comparison Chart in %
Loading...
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLM vs. BIXT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Buy and BIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APLM: $6.51 vs. BIXT: $0.11)
Brand notoriety: APLM and BIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 104% vs. BIXT: 25%
Market capitalization -- APLM: $7.18M vs. BIXT: $9.39M
APLM [@Biotechnology] is valued at $7.18M. BIXT’s [@Biotechnology] market capitalization is $9.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 1 FA rating(s) are green whileBIXT’s FA Score has 0 green FA rating(s).

  • APLM’s FA Score: 1 green, 4 red.
  • BIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, APLM is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 5 TA indicator(s) are bullish while BIXT’s TA Score has 1 bullish TA indicator(s).

  • APLM’s TA Score: 5 bullish, 3 bearish.
  • BIXT’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, APLM is a better buy in the short-term than BIXT.

Price Growth

APLM (@Biotechnology) experienced а +14.31% price change this week, while BIXT (@Biotechnology) price change was -3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIXT($9.39M) has a higher market cap than APLM($7.18M). BIXT YTD gains are higher at: 17.375 vs. APLM (-33.231). BIXT has less debt than APLM: BIXT (1.26M) vs APLM (4.72M).
APLMBIXTAPLM / BIXT
Capitalization7.18M9.39M76%
EBITDAN/A-2.38M-
Gain YTD-33.23117.375-191%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A4.35K-
Total Debt4.72M1.26M375%
FUNDAMENTALS RATINGS
BIXT: Fundamental Ratings
BIXT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMBIXT
RSI
ODDS (%)
Bearish Trend 5 days ago
43%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
51%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CZMWY66.220.95
+1.46%
Carl Zeiss Meditec AG
FUPBY13.940.08
+0.54%
FUCHS SE
JAXAF0.04N/A
N/A
VINYL GROUP LTD.
AKAFF13.72N/A
N/A
Akatsuki Inc.
MIAPF10.68N/A
N/A
MINTO APT REAL ESTATE INVT TR

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with HCWB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then HCWB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+1.51%
HCWB - APLM
46%
Loosely correlated
+6.64%
RVMD - APLM
33%
Poorly correlated
-1.52%
FATE - APLM
28%
Poorly correlated
-5.45%
KURA - APLM
28%
Poorly correlated
-1.05%
ARTL - APLM
27%
Poorly correlated
-1.08%
More

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
-5.70%
CING - BIXT
26%
Poorly correlated
-1.22%
CYTK - BIXT
22%
Poorly correlated
-2.21%
APLM - BIXT
21%
Poorly correlated
+1.51%
ANEB - BIXT
20%
Poorly correlated
+2.11%
TTNP - BIXT
20%
Poorly correlated
-1.79%
More